Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $162 Million
  • Q1 2025

Great Point Partners LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $162 Million distributed in 32 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $14.9M, Kal Vista Pharmaceuticals, Inc. with a value of $11.7M, Evolus, Inc. with a value of $11.4M, Immunovant, Inc. with a value of $10.3M, and Viridian Therapeutics, Inc.\De with a value of $10.1M.

Examining the 13F form we can see an increase of $10.1M in the current position value, from $152M to 162M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $162 Million
Healthcare: $160 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$10.9M
$2.86 Million 1.77% of portfolio
4,683,711
Q4 2024 Reduced 32.46%
$0
$1.85 Million 1.14% of portfolio
2,645,128
Q4 2024 Reduced 5.22%

Summary

  • Portfolio
  • No. of Stocks 32
  • Current Value $162 Million
  • Prior Value $152 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 9 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email